NASDAQ: CNSP
Cns Pharmaceuticals Inc Stock Ownership - Who owns Cns Pharmaceuticals?

Insider buying vs selling

Have Cns Pharmaceuticals Inc insiders been buying or selling?

No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when CNSP insiders and whales buy or sell their stock.

CNSP Shareholders

What type of owners hold Cns Pharmaceuticals Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Cortice Biosciences Inc92.44%573,368$4.24MInsider
John M. Climaco34.77%215,676$1.59MInsider
Waldemar Priebe25.28%156,807$1.16MInsider
Christopher Downs16.68%103,438$764.41kInsider
Jerzy Gumulka6.93%43,006$317.81kInsider
Carl Anthony Evans5.39%33,458$247.25kInsider
Drw Securities LLC2.27%14,050$103.83kInstitution
Jeffry R. Keyes1.79%11,100$82.03kInsider
Ubs Group Ag1.70%10,520$77.74kInstitution
Morgan Stanley0.00%28$206.92Institution

1 of 2

CNSP vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
CNSP2.12%97.88%
JAGX0.94%99.06%
ENSC7.64%92.36%
XBIO1.41%98.59%
MTNB0.98%99.02%

Cns Pharmaceuticals Stock Ownership FAQ

Who owns Cns Pharmaceuticals?

Cns Pharmaceuticals (NASDAQ: CNSP) is owned by 3.97% institutional shareholders, 183.28% Cns Pharmaceuticals insiders, and 0.00% retail investors. Cortice Biosciences Inc is the largest individual Cns Pharmaceuticals shareholder, owning 573,368.00 shares representing 92.44% of the company. Cortice Biosciences Inc's Cns Pharmaceuticals shares are currently valued at $3.97M.

If you're new to stock investing, here's how to buy Cns Pharmaceuticals stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.